Symmetry Medical to Present at Wachovia Healthcare Conference

* Reuters is not responsible for the content in this press release.

Tue Jan 22, 2008 9:02am EST

WARSAW, Ind., Jan. 22 /PRNewswire-FirstCall/ -- Symmetry Medical Inc.
(NYSE: SMA), an independent provider of products to the global orthopedic
device industry and other medical markets, announced today that Brian S.
Moore, President and Chief Executive Officer, is scheduled to present at the
Wachovia Healthcare Conference at the Langham Hotel, in Boston, MA on
Wednesday, January 30, 2008 at 3:00 p.m. EST.
    A live Web cast of the presentation will be available on Symmetry
Medical's Web site at www.symmetrymedical.com. Presentation slides will be
posted on the Web site before the presentation begins. A replay of the Web
cast will be available for 30 days after the date of the presentation.
    About Symmetry Medical Inc.
    Symmetry Medical Inc. is a leading independent provider of implants and
related instruments and cases to the orthopedic device industry. The Company
also designs, develops and produces these products for companies in other
segments of the medical device market, including arthroscopy, dental,
laparoscopy, osteobiologic and endoscopy sectors and provides limited
specialized products and services to non-healthcare markets, such as the
aerospace market.
    Investors/Media:                     Contact:
    The Ruth Group                       Symmetry Medical Inc.
    Nick Laudico/Jason Rando             Fred L. Hite
    (646) 536-7030/7025                  Senior Vice President
    nlaudico@theruthgroup.com            Chief Financial Officer
    jrando@theruthgroup.com              (574) 371-2218

SOURCE  Symmetry Medical Inc.

Investors/Media, Nick Laudico, +1-646-536-7030, nlaudico@theruthgroup.com, or
Jason Rando, +1-646-536-7025, jrando@theruthgroup.com, both of The Ruth Group;
or Fred L. Hite, Senior Vice President, Chief Financial Officer of Symmetry
Medical Inc., +1-574-371-2218
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.